Seminars in Nephrology
Volume 27, Issue 5 , Pages 565-571 , September 2007

Renal Sodium Handling and Nighttime Blood Pressure

References 

  1. Smolenski MH, Haus E. Circadians rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14:280S–290S
  2. Pickering TG. Diurnal rhythms and other sources of blood pressure variability in normal and hypertensive subjects. In:  Laragh J,  Brenner BM editor. Hypertension: pathophysiology, diagnosis and management. Vol I:New York: Raven Press; 1990;p. 1397–1405
  3. Portaluppi F, Smolenski MH. Time-dependent structure and control of arterial blood pressure. Ann NY Acad Sci. 1996;783:1–342
  4. Baumgart P. Circadian rhythm of blood pressure: internal and external time triggers. Chronobiol Int. 1991;8:444–450
  5. Sternberg H, Rosenthal T, Shamiss A, Green M. Altered circadian rhythm of blood pressure in shift worker. J Hum Hypertens. 1995;9:349–353
  6. Kario K, Pickering TG, Matsuo T, et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–857
  7. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. J Hypertens. 1998;16:733–738
  8. Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive. Am J Hypertens. 2000;13:1035–1038
  9. Cuspidi C, Lonati L, Sampieri L, et al. Impact of nocturnal fall in blood pressure on early cardiovascular changes in essential hypertension. J Hypertens. 1999;17:1339–1344
  10. Nishimura M, Uzu T, Fujii T, Kimura G. Disturbed circadian rhythm of urinary albumin excretion in non-dipper type of essential hypertension. Am J Nephrol. 2002;22:455–462
  11. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805
  12. Ohkubo T, Hozawa A, Nagai K, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens. 2000;18:847–854
  13. Imai Y, Tsuji I, Nagai K, et al. Circadian blood pressure variation related to morbidity and mortality from cerebrovascular and cardiovascular diseases. Ann N Y Acad Sci. 1996;783:172–185
  14. Bjorklund K, Lind L, Andren B, Lithell H. The majority of nondipping men do not have increased cardiovascular risk—a population based study. J Hypertens. 2002;20:1501–1506
  15. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15:357–364
  16. Davidson MB, Hix JK, Vidt DJ, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166:846–852
  17. Staessen J, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension (Systolic Hypertension in Europe Trial Investigators). JAMA. 1999;282:539–546
  18. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415
  19. Staessen JA, Birkenhager W, Bulpitt CJ, et al. The relationship between blood pressure and sodium and potassium excretion during the day and at night. J Hypertens. 1993;11:443–447
  20. Uzu T, Ishikawa K, Fujii T, et al. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997;96:1859–1862
  21. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100:1635–1638
  22. Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627–1632
  23. Bankir L, Sellin F, Maillard M, Chiolero A, Burnier M. Influence of moderate body weight excess on the nycthemeral pattern of blood pressure, renal function and sodium and water excretion in patients with essential hypertension. Arch Mal Coeur Vaiss. 2004;97:777–781
  24. Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 2004;65:621–625
  25. Fukuda M, Motokawa M, Miyagi S, et al. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006;21:2172–2177
  26. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med Hypotheses. 2006;67:802–806
  27. Mansoor GA, Tsimikas JV, Dauser D, et al. Assessment of factors associated with nocturnal blood pressure changes on 2 sessions of ambulatory blood pressure monitoring (The DREAM study). [abstract] J Clin Hypertens. 2006;8(Suppl A):120
  28. Burnier M, Bochud M, Maillard M, Bovet P. The nycthemeral pattern of urinary sodium excretion is a significant determinant of nighttime blood pressure and of the dipping profile in families of African descent. [abstract] J Am Soc Nephrol. 2005;16:176A
  29. Eguchi K, Kasahara K, Nagashima A, et al. Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure “riser” pattern. Hypertens Res. 2002;25:467–473
  30. Uzu T, Nishimura M, Fujii T, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–1748
  31. Zacharieva S, Orbetzova M, Elenkova A, et al. Diurnal blood pressure pattern in patients with primary aldosteronism. J Endocrinol Invest. 2006;29:26–31
  32. Zelinka T, Štrauch B, Pecen L, et al. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism an Cushing’s syndrome. J Hum Hypertens. 2004;18:107–111
  33. Sturrock NDC, George E, Pound N, et al. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17:360–364
  34. Goto N, Uchida K, Morozumi K, et al. Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens Res. 2005;28:301–306
  35. Liu M, Takahashi H, Morita Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant. 2003;18:563–569
  36. Goyal D, Macfadyen RJ, Watson RD, et al. Ambulatory blood pressure monitoring in heart failure: a systematic review. Eur J Heart Fail. 2005;7:149–156
  37. van den Dorpel M, van den Meiracker A, Lameris T, et al. Cyclosporin A impairs the nocturnal blood pressure fall in renal transplant recipients. Hypertension. 1996;28:304–307
  38. Taler S, Textor S, Canzanello V, et al. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. Am J Hypertens. 1995;8:598–605
  39. David O, McGregor G, Olsson C, et al. Autonomic dysfunction and ambulatory blood pressure in renal transplant recipients. Transplantation. 2001;71:1277–1281
  40. Gatzka CD, Schobel HP, Klingbeil AU, et al. Normalization of circadian blood pressure profiles after renal transplantation. Transplantation. 1995;59:1270–1274
  41. Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin and non-cyclosporin treated renal transplant recipients. J Hypertens. 1993;11:439–442
  42. Reitblat T, Zamir D, Estis L, et al. The different patterns of blood pressure elevation by rofecoxib and nabumetone. J Hum Hypertens. 2002;16:431–434
  43. Hermida R, Ayala D, Calvo C, et al. Administration time-dependent effect of aspirin on blood pressure in untreated hypertensive patients. Hypertension. 2003;41:1259–1267
  44. Sowers JR, White WB, Pitt B, et al. The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:161–168
  45. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther. 1999;66:76–84

PII: S0270-9295(07)00093-9

doi: 10.1016/j.semnephrol.2007.07.007

Seminars in Nephrology
Volume 27, Issue 5 , Pages 565-571 , September 2007

Article Tools

* Image Usage & Resolution